GeneOne Life Science Inc (011000) — Cash Flow Reinvestment Rate

Latest as of December 2021: 32.88x

GeneOne Life Science Inc (011000) has a Cash Flow Reinvestment Rate of 32.88x as of December 2021, reinvesting ₩120.54 Billion (capex ₩35.40 Billion plus investments ₩-85.14 Billion) from operating cash flow of ₩3.67 Billion. See 011000 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

32.88x

(Capex + Investments) / Operating CF

Total Reinvested

₩120.54 Billion

Capex + Investments

Operating Cash Flow

₩3.67 Billion

KRW

Capital Expenditures

₩35.40 Billion

KRW

GeneOne Life Science Inc Cash Flow Reinvestment Rate (2015–2015)

Historical reinvestment intensity for GeneOne Life Science Inc across 1 annual periods. For the full cash flow conversion analysis, see GeneOne Life Science Inc (011000) cash conversion ratio.

Annual Cash Flow Reinvestment Rate for GeneOne Life Science Inc (2015–2015)

Year-by-year capital reinvestment analysis for GeneOne Life Science Inc. See financial flexibility index of GeneOne Life Science Inc to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (KRW)	Operating CF	Capex	YoY Change
2015	3.34x	₩2.60 Billion	₩778.50 Million	₩2.04 Billion	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow